Dong ZR - Search Results

1

Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.

Dong ZR, Cai JB, Shi GM, Yang YF, Huang XY, Zhang C, Dong RZ, Wei CY, Li T, Ke AW, Fan J. Dong ZR, et al. Among authors: dong rz. Cancer Lett. 2023 Jun 28;564:216186. doi: 10.1016/j.canlet.2023.216186. Epub 2023 Apr 25. Cancer Lett. 2023. PMID: 37105392

2

An unusual cause of unilateral urinary tract obstruction.

Li T, Sun BZ, Zhi XT, Qu SF, Dong ZR, Hu SY. Li T, et al. Among authors: dong zr. Surgery. 2012 May;151(5):764-5. doi: 10.1016/j.surg.2010.12.012. Surgery. 2012. PMID: 22645738 No abstract available.

3

Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients.

Huang XY, Zhang C, Cai JB, Shi GM, Ke AW, Dong ZR, Zhang PF, Fan J, Peng BG, Zhou J. Huang XY, et al. Among authors: dong zr. PLoS One. 2014 May 9;9(5):e96860. doi: 10.1371/journal.pone.0096860. eCollection 2014. PLoS One. 2014. PMID: 24816558 Free PMC article.

4

Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.

Li T, Dong ZR, Guo ZY, Wang CH, Zhi XT, Zhou JW, Li DK, Chen ZT, Chen ZQ, Hu SY. Li T, et al. Among authors: dong zr. Liver Int. 2015 Apr;35(4):1416-29. doi: 10.1111/liv.12644. Epub 2014 Aug 21. Liver Int. 2015. PMID: 25066210

5

Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.

Zhang C, Liu LX, Dong ZR, Shi GM, Cai JB, Zhang PF, Ke AW, Yu JX, Zhou J, Fan J. Zhang C, et al. Among authors: dong zr. Tumour Biol. 2015 Mar;36(3):1781-9. doi: 10.1007/s13277-014-2780-5. Epub 2014 Nov 13. Tumour Biol. 2015. PMID: 25391422

6

Role of 5-hydroxymethylcytosine level in diagnosis and prognosis prediction of intrahepatic cholangiocarcinoma.

Dong ZR, Zhang C, Cai JB, Zhang PF, Shi GM, Gao DM, Sun HC, Qiu SJ, Zhou J, Ke AW, Fan J. Dong ZR, et al. Tumour Biol. 2015 Apr;36(4):2763-71. doi: 10.1007/s13277-014-2900-2. Epub 2014 Dec 6. Tumour Biol. 2015. PMID: 25480415

7

Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression.

Cai JB, Shi GM, Dong ZR, Ke AW, Ma HH, Gao Q, Shen ZZ, Huang XY, Chen H, Yu DD, Liu LX, Zhang PF, Zhang C, Hu MY, Yang LX, Shi YH, Wang XY, Ding ZB, Qiu SJ, Sun HC, Zhou J, Shi YG, Fan J. Cai JB, et al. Among authors: dong zr. Hepatology. 2015 May;61(5):1603-14. doi: 10.1002/hep.27682. Epub 2015 Feb 13. Hepatology. 2015. PMID: 25557975

8

Postoperative adjuvant transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: a retrospective analysis.

Dong ZR, Zhang PF, Wang CH, Zhang C, Cai JB, Shi GM, Ke AW, Sun HC, Qiu SJ, Zhou J, Fan J. Dong ZR, et al. Am J Cancer Res. 2014 Dec 15;5(1):450-7. eCollection 2015. Am J Cancer Res. 2014. PMID: 25628953 Free PMC article.

9

BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma.

Zhang P, Dong Z, Cai J, Zhang C, Shen Z, Ke A, Gao D, Fan J, Shi G. Zhang P, et al. Int J Immunopathol Pharmacol. 2015 Mar;28(1):36-44. doi: 10.1177/0394632015572070. Int J Immunopathol Pharmacol. 2015. PMID: 25816404 Free article.

10

TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection.

Wang CH, Guo ZY, Chen ZT, Zhi XT, Li DK, Dong ZR, Chen ZQ, Hu SY, Li T. Wang CH, et al. Among authors: dong zr. Sci Rep. 2015 Jul 20;5:12366. doi: 10.1038/srep12366. Sci Rep. 2015. PMID: 26190376 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page